Molecular Docking Studies for the Identification of Mycobacterial Adenosine Triphosphate (ATP) Synthase Inhibitors Using Active Phytocompounds from Plants Curcuma longa, Curcuma zedoaria and Galipea officinalis


Year : 2024 | Volume :02 | Issue : 01 | Page : 16-26
    By

    Priyanka Raja,

  • Shubham Wanarase,

  1. Research Intern, , Department Of Bioinformatics, BioNome, Bengaluru, Karnataka, India
  2. Bioinformatics Associate, Department Of Bioinformatics, BioNome, Bengaluru., Karnataka, India

Abstract

Objective: Tuberculosis (TB), known in human history for several decades, remains the second leading infectious disease after COVID-19. Still, the occurrence of TB increases due to the bacterium’s greater survival nature. They can survive in extreme conditions by being in long latency and adapting to the host. This study seeks to identify potential inhibitors from Curcuma longa, Curcuma zeodaria, and Galipea officinalis based on ancient folklore and compare them against the known mycobacterial ATP-synthase inhibitor, bedaquiline. To perform docking studies, drug-likeness, and ADMET analysis.

Methods: The structure of mycobacterial ATP-synthase was retrieved from the PDB database. Preparation of protein and docking studies were performed using the PyRx tool for the drug-likeliness study, the SwissADME webserver was used. For ADMET analysis, the ADMETlab webserver was used.

Results: The docking study showed potential compounds that inhibit mycobacterial ATP-synthase thereby interfering with ATP synthesis besides the known inhibitor, bedaquiline. Among these six compounds, cyclocurcumin, cusparine, and galipeine had shown a similar binding nature compared to that of bedaquiline. The known inhibitor, bedaquiline inhibits the protein by blocking the rotation of the C chain which is the catalytic headpiece. Thus, it primarily inhibits the F-ATP synthesis in the bacterium.

Conclusion: Considering the drug-likeliness and ADMET analysis, galipeine shows better safety and toxicity profile than Cyclocurcumin. The study proposes Cyclocurcumin and galipeine as potential inhibitors of mycobacterial ATP-synthase for designing a therapeutic compound, by exploiting the phytocompounds especially known for their purpose for treating tuberculosis based on ancient folklore.

Keywords: Tuberculosis, mycobacterial ATP-synthase, Curcuma longa, Curcuma zeodaria; Galipea officinalis, traditional medicine

[This article belongs to International Journal of Bioinformatics and Computational Biology (ijbcb)]

aWQ6MTQ4MTk3fGZpbGVuYW1lOmNhYzE4NTQwLWYucG5nfHNpemU6dGh1bWJuYWls
How to cite this article:
Priyanka Raja, Shubham Wanarase. Molecular Docking Studies for the Identification of Mycobacterial Adenosine Triphosphate (ATP) Synthase Inhibitors Using Active Phytocompounds from Plants Curcuma longa, Curcuma zedoaria and Galipea officinalis. International Journal of Bioinformatics and Computational Biology. 2024; 02(01):16-26.
How to cite this URL:
Priyanka Raja, Shubham Wanarase. Molecular Docking Studies for the Identification of Mycobacterial Adenosine Triphosphate (ATP) Synthase Inhibitors Using Active Phytocompounds from Plants Curcuma longa, Curcuma zedoaria and Galipea officinalis. International Journal of Bioinformatics and Computational Biology. 2024; 02(01):16-26. Available from: https://journals.stmjournals.com/ijbcb/article=2024/view=148204


Browse Figures

References

1.Adigun R,Singh R.Tuberculosis. StatPearls [online]. 2023 Jul 11. Available from: https://www.statpearls.com/ArticleLibrary/viewarticle/30653#/ 2. Chai Q, Zhang Y, Liu CH. Mycobacterium tuberculosis: an adaptable pathogen associated with multiple human diseases. Front Cell Infect Microbiol. 2018 May 15;8:158. 3. Shetye GS, Franzblau SG, Cho S. New tuberculosis drug targets, their inhibitors, and potential therapeutic impact. Transl Res. 2020 Mar; [Epub ahead of print]. 4. Biuković G, Basak S, Manimekalai MSS, Rishikesan S, Roessle M, Dick T, et al. Variations of subunit ε of the Mycobacterium tuberculosis F1Fo ATP synthase and a novel model for mechanism of action of the tuberculosis drug TMC207. Antimicrob Agents Chemother. 2013 Jan;57(1): 168–76. 5. Preiss L, Langer JD, Yildiz Ö, Eckhardt-Strelau L, Guillemont JEG, Koul A, et al. Structure of the mycobacterial ATP synthase rotor ring in complex with the anti-TB drug bedaquiline. Sci Adv. 2015 May;1(4). 6. Tran SL, Cook GM. The F1Fo-ATP synthase of Mycobacterium smegmatis is essential for growth. J Bacteriol [online]. 2005 Jul 1;187(14):5023–8. DOI: 10.1128/JB.187.14.5023-5028.2005 7. Widyowati R, Agil M. Chemical constituents and bioactivities of several Indonesian plants typically used in Jamu. Chem Pharm Bull [online]. 2018 May 1;66(5):506–18. DOI: 10.1248/cpb.c17-00966 8. Houghton PJ, Watabe Y, Woldemariam TZ, Yates MD. Activity of alkaloids from Angostura bark against Mycobacterium tuberculosis. J Pharm Pharmacol. 1998 Sep 1;50(Suppl 9):230–0. 9. Diaz G, Miranda IL, Diaz MAN. Quinolines, isoquinolines, angustureine, and congeneric alkaloids—occurrence, chemistry, and biological activity [online]. In: Phytochemicals - Isolation, Characterisation and Role in Human Health. IntechOpen; 2015. 10. Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol. 2014 Dec 22;1263:243–50. 11. Ahmad Z, Laughlin TF. Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides. Curr Med Chem. 2023;17(25):2822–36. DOI: 10.2174/092986710791859270 12. O’Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminform. 2011 Oct 7;3(1). 13. Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J Chem Inf Model. 2021 Jul 19;61(8). 14. Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2009;31(2):455–61. 15. Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017 Mar 3;7(1). Available from: https://www.nature.com/articles/srep42717 16. Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 2004 Dec;1(4):337–41. 17. Daina A, Zoete V. A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. Chem Med Chem. 2016 May 24;11(11):1117–21. 18. Xiong G, Wu Z, Yi J, Fu L, Yang Z, Hsieh C, et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 2021 Apr 24;49(W1)W5–14. DOI: 10.1093/nar/gkab255 19. Savjani KT, Gajjar AK, Savjani JK. Drug solubility: importance and enhancement techniques. ISRN Pharm. 2012 Jul 5;2012:1–10. DOI: 10.5402/2012/195727 20. Chen C, Lee MH, Weng C, Leong MK. Theoretical prediction of the complex P-glycoprotein substrate efflux based on the novel hierarchical support vector regression scheme. Molecules. 2018 Jul 22;23(7):1820. DOI: 10.3390/molecules23071820.


Regular Issue Subscription Original Research
Volume 02
Issue 01
Received 25/01/2024
Accepted 23/05/2024
Published 29/05/2024